FDA approves new breast cancer drug based on VIKTORIA-1 study results

FDA approves new breast cancer drug based on VIKTORIA-1 study results

New targeted drug brings ‘big change, big benefit,’ per Fred Hutch’s Dr. Sara Hurvitz, who led the study
Hutch NewsJuly 16, 2026